Net sales for the fourth quarter of 2025 were $7.8 billion, an increase of 14.8% from $6.8 billion in the fourth quarter of 2024, with organic sales¹ growing by 14.4%. The growth was primarily driven by higher volume, with both the Medline brand and supply chain solutions business segments delivering strong growth.